201 related articles for article (PubMed ID: 9488594)
1. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
[TBL] [Abstract][Full Text] [Related]
2. Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues.
Li YF; Zhang R
J Chromatogr B Biomed Appl; 1996 Nov; 686(2):257-65. PubMed ID: 8971608
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
4. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
Zhao YX; Liu DX; Liang WQ; Ye ZW
J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and pharmacokinetics following oral administration of natural product DNA topoisomerase I inhibitors 10-hydroxycamptothecin and camptothecin in SCID mice bearing human breast cancer xenografts.
Zhang R; Cai Q; Lindsey J; Li Y; Chambless B; Naguib F
Int J Oncol; 1997 Jun; 10(6):1147-56. PubMed ID: 21533497
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer.
Ping YH; Lee HC; Lee JY; Wu PH; Ho LK; Chi CW; Lu MF; Wang JJ
Oncol Rep; 2006 May; 15(5):1273-9. PubMed ID: 16596197
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C.
Zhang X; Zhang R; Zhao H; Cai H; Gush KA; Kerr RG; Pettit GR; Kraft AS
Cancer Res; 1996 Feb; 56(4):802-8. PubMed ID: 8631017
[TBL] [Abstract][Full Text] [Related]
9. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
11. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice.
Hu W; Zhang C; Hu W; Fang Y; Hou W
Fitoterapia; 2012 Oct; 83(7):1291-8. PubMed ID: 22858157
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyethyl starch-10-hydroxy camptothecin conjugate: synthesis, pharmacokinetics, cytotoxicity and pharmacodynamics research.
Li G; Cai C; Qi Y; Tang X
Drug Deliv; 2016; 23(1):277-84. PubMed ID: 24833272
[TBL] [Abstract][Full Text] [Related]
15. Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
Zhao Y; Gao J; Sun X; Chen H; Wu L; Liang W
J Pharm Pharm Sci; 2007; 10(1):61-70. PubMed ID: 17498395
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
[TBL] [Abstract][Full Text] [Related]
17. A two-step pH-dependent liquid-liquid extraction combined with HPLC-fluorescence method for the determination of 10-hydroxycamptothecin in mouse liver tissue.
Zheng J; Guo H; Guo N; Ma W; Jing L; Zhang R; Dai Z; Yan X; Wang Y; Wang Z
Pharm Biol; 2012 Aug; 50(8):954-61. PubMed ID: 22486519
[TBL] [Abstract][Full Text] [Related]
18. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
Shi K; Tian Y; Jiang Y; Wang L; Cui F
Pharm Dev Technol; 2010 Dec; 15(6):644-52. PubMed ID: 19943738
[TBL] [Abstract][Full Text] [Related]
19. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
Zheng J; Ji Y; Shao C; Jing L; Wang Y
J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]